As of 3:59pm ET
| -0.01 / -0.69%|
The 2 analysts offering 12-month price forecasts for Biocept Inc have a median target of 2.25, with a high estimate of 2.50 and a low estimate of 2.00. The median estimate represents a +56.25% increase from the last price of 1.44.
The current consensus among 2 polled investment analysts is to Buy stock in Biocept Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.